ContraFect Corporation (CFRX): Price and Financial Metrics
CFRX Price/Volume Stats
Current price | $0.05 | 52-week high | $13.02 |
Prev. close | $0.07 | 52-week low | $0.04 |
Day low | $0.05 | Volume | 910,200 |
Day high | $0.06 | Avg. volume | 1,391,360 |
50-day MA | $0.28 | Dividend yield | N/A |
200-day MA | $1.22 | Market Cap | 535.25K |
CFRX Stock Price Chart Interactive Chart >
ContraFect Corporation (CFRX) Company Bio
ContraFect Corporation, a biotechnology company, focuses on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases in the United States. The company was founded in 2008 and is based in Yonkers, New York.
Latest CFRX News From Around the Web
Below are the latest news stories about CONTRAFECT CORP that investors may wish to consider to help them evaluate CFRX as an investment opportunity.
ContraFect files for stock and warrants offering to raise $15MMore on Contrafect... |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayIt's time to start off the workweek with a detailed breakdown of the biggest pre-market stock movers for Monday morning! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayWe're starting off Thursday with a breakdown of the biggest pre-market stock movers traders need to know about this morning! |
Why Is ContraFect (CFRX) Stock Up 23% Today?ContraFect stock is on the move Monday with heavy trading of CFRX as investors react to the latest clinical trial update from the FDA! |
Why Is Sigma Additive Solutions (SASI) Stock Down 27% Today?Sigma Additive Solutions stock is sliding lower on Monday as shares of SASI give up gains from an acquisition announcement on Friday! |
CFRX Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | -91.23% |
1-year | -97.72% |
3-year | -99.99% |
5-year | -99.98% |
YTD | N/A |
2023 | 0.00% |
2022 | -96.35% |
2021 | -47.92% |
2020 | -18.64% |
2019 | -59.43% |
Loading social stream, please wait...